Peers Ponder Review

File PhotoThe peer-review system of the German Research Foundation (DFG) is unique, as proposals are reviewed by experts nominated and elected by the scientific community. This will change in the spring, however, when the DFG will select the reviewers; the elected representatives will be responsible for quality control and for writing funding recommendations based on the initial reviews. The DFG claims that the reform strengthens the principle of academic self-government, but critics of the new

Written byMartina Habeck
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

File Photo

The peer-review system of the German Research Foundation (DFG) is unique, as proposals are reviewed by experts nominated and elected by the scientific community. This will change in the spring, however, when the DFG will select the reviewers; the elected representatives will be responsible for quality control and for writing funding recommendations based on the initial reviews. The DFG claims that the reform strengthens the principle of academic self-government, but critics of the new system warn that the DFG is reaching for power.

According to Reinhard Jahn at the Max Planck Institute for Biophysical Chemistry in Göttingen, the reform was overdue. "It adapts a system that has long been in practice, albeit without [legitimacy]," says Jahn, who currently chairs the review committee in biology. He points out that since the DFG formation 50 years ago, the number of funding proposals has increased dramatically and research fields have become ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies